Biotech Essentials

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 16.06.2021.

#BIODigital
#IamBIO
#GoodDayBIO
#COVIDvaccine
#pfizer

Companies And Industries

@BIOConvention shared
On Jun 14, 2021
RT @IAmBiotech: Biotech reacted to the pandemic with remarkable speed, changing the course of history and the industry in the process. @DrMichelleBIO digs into the story in the new #BIODigital preview episode of the #IamBIO Podcast, brought to you by @FujifilmDiosyn. https://t.co/8JbHmDkzRO
Open
Biotech Changed COVID. But Did COVID change Biotech? I AM BIO

Biotech Changed COVID. But Did COVID change Biotech? I AM BIO

‎Show I AM BIO, Ep Biotech Changed COVID. But Did COVID change Biotech? - Jun 14, 2021

@BIOConvention shared
On Jun 10, 2021
RT @IAmBiotech: #GoodDayBIO: What BIO’s doing to improve clinical trial diversity. A look ahead at some important food sustainability events we’ll be watching this year. Plus, details on how you can participate in #BIODigital. https://t.co/5Le9IJ7ua2
Open
Good Day BIO: Health equity requires clinical trial diversity

Good Day BIO: Health equity requires clinical trial diversity

Today, we have news on what BIO’s doing to improve clinical trial diversity plus a look ahead at some important food sustainability events we’ll be watching this year. Also, BIO Digital ...

@kiranshaw shared
On Jun 14, 2021
Bharat Biotech has shared Covaxin research data in full and promises final Phase III results soon. https://t.co/jjXPd2KUjc
Open
Bharat Biotech shares Covaxin research data in full, promises final Phase III results soon

Bharat Biotech shares Covaxin research data in full, promises final Phase III results soon

Bharat Biotech stated that Covaxin is the only Covid vaccine to have published data on most emerging variants.Final analysis data for Covaxin will be submitted to CDSCO first, and then to ...

@kiranshaw shared
On Jun 14, 2021
UPDATED: Long-awaited Novavax PhIII results show 90.3% overall efficacy, with 100% effectiveness against moderate and severe Covid-19 – Endpoints News. That’s good news for India’s vaccine armoury. ⁦@SerumInstIndia⁩ https://t.co/lDiAw1Mg4r
Open
UPDATED: Long-awaited Novavax PhIII results show 100% efficacy against moderate and severe Covid-19

UPDATED: Long-awaited Novavax PhIII results show 100% efficacy against moderate and severe Covid-19

After several months of delays and setbacks, the small Maryland biotech Novavax has finally completed its North American Phase III trial for its Covid-19 vaccine. And though they say the ...

@kiranshaw shared
On Jun 11, 2021
Covid-19 has given South Korea’s biotech firms a shot in the arm | The Economist - Has India inadvertently ceded its premier global position by protectionist policy measures? Time for introspection on post Covid fallout. https://t.co/KyljgwY0B7
Open
Covid-19 has given South Korea’s biotech firms a shot in the arm

Covid-19 has given South Korea’s biotech firms a shot in the arm

For a booster, they must look to themselves | Business

@CellCultureDish shared
On Jun 11, 2021
Weekly Biotechnology News Wrap-Up - 06/11/2021 - https://t.co/JsovQ3DT9B
Open
The Dish’s Weekly Biotechnology News Wrap Up – June 11, 2021

The Dish’s Weekly Biotechnology News Wrap Up – June 11, 2021

*|RSSFEED:DATE|* Incase you missed it. We summarized the week's top biotechnology stories.

@biospace shared
On Jun 16, 2021
How Biotech saved the world: Pfizer CEO opens up and shares what’s next #pfizer #COVIDvaccine https://t.co/bXsavPaVf8
Open
How Biotech Saved the World: Pfizer CEO Opens Up and Shares What’s Next

How Biotech Saved the World: Pfizer CEO Opens Up and Shares What’s Next

A sense of urgency, powerful science, relentless ingenuity, hope and trust drove the development of Pfizer and BioNTech’s mRNA vaccine during the height of the COVID-19 pandemic. As the ...

@matthewherper shared
On Jun 12, 2021
Alzheimer's Association blasts Biogen over price of new drug Aduhelm https://t.co/5QcYJlRiBs
Open
‘Simply unacceptable’: Alzheimer’s Association blasts Biogen over the price of its new medicine

‘Simply unacceptable’: Alzheimer’s Association blasts Biogen over the price of its new medicine

The price "will pose an insurmountable barrier to access … and may further deepen issues of health equity," the advocacy group argued.

Read more: Companies And Industries
weekly 16.06.2021
View archives
Back to home

Subscribe to Biotech Essentials - Companies & Industries.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Companies & Industries.
Privacy Policy

Sign up for the weekly Biotech Essentials - Companies & Industries newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Companies & Industries weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy